Loading provider…
Loading provider…
Ophthalmology Physician in Northridge, CA
NPI: 1003808494Primary Employer
California Eye Care Managed Eye Care Specialists a Medical Group Inc.
californiaeyespecialists.com
HQ Phone
Get M.D. Andrew's Phone Numberphone_androidMobile
Get M.D. Andrew's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1987 - 2027

American Board of Ophthalmology
Ophthalmology
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye Institutes
Residency • Ophthalmology
1987 - 1990
UCLA David Geffen School of Medicine/UCLA Medical Center
Internship • Internal Medicine
1986 - 1987
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 489 | 572 |
| 2 | 92134Diagnostic imaging of retina | 162 | 179 |
| 3 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 161 | 161 |
| 4 | 92250Photography of the retina | 142 | 147 |
| 5 | 92012Eye and medical examination for diagnosis and treatment, established patient | 108 | 181 |
Infographic: study design of the BALATON and COMINO phase 3 randomised trials of faricimab in patients with retinal vein occlusion.
Authors: Andrew Chang, Aachal Kotecha, Faiz Kermani, Insaf Saffar
'Long-term Anti-Vascular Endothelial Growth Factor Treatment for Neovascular
Authors: Park, Un Chul, Shin, Joo Young, McCarthy, Linda C, Kim, Sang Jin, Park, Jung Hyun, Chung, Hum, Yu, Hyeong Gon
Journal: Mol Vis
Publication Date: 2014-12-19
'Infographic: study design of the BALATON and COMINO phase 3 randomised trials
Authors: Andrew Chang, Aachal Kotecha, Faiz Kermani, Insaf Saffar
Publication Date: 2024-08
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DIAGNOSTIC_TEST: DetermaRX
Lead Sponsor: University of Malaya
Intervention / Treatment: DEVICE: Conventional TBA, DEVICE: 3D TBA
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Matching Placebo, DRUG: OCA